| |
| |
|
| Insider
Information: |
Anzalone Christopher Richard |
| Relationship: |
Chief Executive Office... |
| City: |
Pasadena |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,715,048 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$92,021,739 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,715,048 |
|
|
| Total
Value |
$92,021,739 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -37.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arrowhead Pharmaceuticals Inc |
ARWR |
Chief Executive Office... |
2024-01-31 |
3,715,048 |
2008-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2020-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,126 |
2,544,621 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2022-07-07 |
4 |
OE |
$14.54 |
$36,365 |
D/D |
2,501 |
4,060,135 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-09-20 |
4 |
S |
$29.00 |
$123,250 |
D/D |
(4,250) |
2,141,903 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-09-20 |
4 |
OE |
$5.10 |
$21,675 |
D/D |
4,250 |
2,146,153 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2024-01-02 |
4 |
AS |
$30.74 |
$308,637 |
D/D |
(9,952) |
3,715,048 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
President and CEO |
• • – |
2010-08-31 |
4 |
B |
$0.89 |
$8,900 |
D/D |
10,000 |
341,729 |
2.81 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2021-12-23 |
4 |
OE |
$5.19 |
$61,273 |
D/D |
11,806 |
3,245,828 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2022-01-07 |
4 |
OE |
$5.19 |
$61,273 |
D/D |
11,806 |
4,057,634 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2023-12-20 |
4 |
AS |
$28.54 |
$342,480 |
D/D |
(12,000) |
3,725,000 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-12-03 |
4 |
AS |
$60.73 |
$740,952 |
D/D |
(12,033) |
2,071,903 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2021-10-20 |
4 |
AS |
$66.23 |
$993,450 |
D/D |
(15,000) |
3,329,022 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2016-06-30 |
4 |
OE |
$5.09 |
$80,279 |
D/D |
15,772 |
1,117,233 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
President and CEO |
• • – |
2014-10-15 |
4 |
B |
$6.32 |
$101,120 |
D/D |
16,000 |
260,173 |
2.81 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2020-12-08 |
4 |
OE |
$2.01 |
$32,811 |
D/D |
16,324 |
2,521,561 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2020-12-08 |
4 |
S |
$67.97 |
$1,109,542 |
D/D |
(16,324) |
2,505,237 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
18,375 |
3,486,689 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-09-25 |
4 |
S |
$28.25 |
$565,000 |
D/D |
(20,000) |
2,121,903 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2023-10-25 |
4 |
AS |
$24.21 |
$589,223 |
D/D |
(24,338) |
3,737,000 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-03-16 |
4 |
AS |
$7.40 |
$192,400 |
D/D |
(26,000) |
1,968,789 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-12-02 |
4 |
AS |
$66.58 |
$2,625,570 |
D/D |
(37,967) |
2,083,936 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2020-12-09 |
4 |
OE |
$2.01 |
$77,739 |
D/D |
38,676 |
2,543,913 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2020-12-09 |
4 |
S |
$67.27 |
$2,670,805 |
D/D |
(38,676) |
2,505,237 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2020-12-18 |
4 |
OE |
$4.75 |
$232,006 |
D/D |
40,510 |
2,545,747 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2022-09-27 |
4 |
OE |
$30.77 |
$1,250,679 |
D/D |
40,624 |
3,468,314 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-09-23 |
4 |
OE |
$5.10 |
$212,951 |
D/D |
41,755 |
2,183,658 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
